Childhood Neurotherapeutics Center
of Economic Excellence
Inception:
2006
University collaborators:
University of South Carolina (fiscal agent)
Medical University of South Carolina (collaborative partner)
About the CoEE:
The Childhood Neurotherapeutics CoEE uses recent advances in pharmacogenetics, metabolic disorders, and neuroinflammatory diseases to study neurological disorders in children. Research at this CoEE will be particularly focused on preventing brain damage in premature infants (neuroprotection) and curing infant brain diseases through cellular engineering.
In collaboration with the Greenville Hospital System, this CoEE operates a statewide team that is developing neural stem cell therapeutic approaches to neurological disorders in children. Neural stem cells have recently been identified as having high repair capacity, particularly during development. This important scientific discovery will allow the CoEE to contribute to the treatment of these disorders and to transfer research knowledge directly to patient application.
This CoEE has been granted two U.S. patents and submitted multiple others.
Funding level:
$5 million
CoEE endowed chairs:
| Chair Name |
|
Status |
| CoEE Endowed Chair in Child and Adolescent Neurochemistry (USC) |
|
Actively recruiting |
| CoEE Endowed Chair in Translational Therapeutics (USC) |
|
Actively recruiting |
| CoEE Endowed Chair Neurodevelopmental Dysfunction (MUSC) |
|
Actively recruiting |
|
